E-support for Healthcare Processes - ASTHMA

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01461642

Acronym

E-ASTHMA

Enrollment

100

Registered

2011-10-28

Start date

2011-10-31

Completion date

2018-01-15

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

Asthma, ICT Support, ACT, PEF

Brief summary

The purpose of the study is to establish and clinically evaluate a new approach to treating asthma by using information and communication technologies (ICT). A mobile environment, and organizational interventions to improve the process of an integrated treatment of people with asthma will be identified, developed, introduced and clinically evaluated.

Detailed description

A mobile environment to improve the process of an integrated treatment of people with asthma will be identified, developed, introduced and clinically evaluated. The study will include 120 patients diagnosed with asthma that is poorly managed. The study will use the ACT (Asthma Control Test) questionnaire and an evaluation questionnaire that will cover issues regarding the satisfaction of subjects with asthma care offered. Subjects with a PEF meter, will be able to enter the value of PEF (Peak Expiratory Flow). In addition to this, users can enter values (1) physical activity (type, duration, intensity), and (2) food (type, quantity).

Interventions

OTHERSelf management asthma plan indorsment.

Subjects adherence to asthma self management plan will be monitored through web-based support.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* ACT points \<19 * Daily symptoms\> = 2 days/week * Night symptoms\> = 1 night/week * Rescue medication \> 2days/week * At least one asthma exacerbation in the past year, but not in the last month, which was treated with oral glucocorticoid

Exclusion criteria

* Worsening of asthma in the last 4 weeks (treated with oral corticosteroids) * Age \>70 or \<18 years * Significant co-morbidity * Does not own or know how to handle a mobile phone * No internet access * Not able to perform a PEF measurment * Not able to use inhalor

Design outcomes

Primary

Measure	Time frame	Description
Number of exacerbations.	1 year	Number of exacerbations per year.

Countries

Slovenia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026